Alexandria, VA | February 26, 2025, Washington University of Science and Technology (WUST) proudly co-organized the 1st International Conference on Artificial Intelligence in Oncology (ICAIO 2025), a landmark hybrid event held at Vishwakarma University, Pune, Maharashtra, India. Bringing together world-renowned experts, researchers, clinicians, and technology leaders from across the globe, the conference marked a historic milestone in the intersection of artificial intelligence and oncological science, and a significant step forward in WUST's growing international research footprint.

ICAIO 2025 was organized by the Faculty of Science and Technology of Vishwakarma University in collaboration with Washington University of Science and Technology, USA, and the Research Cell of Vishwakarma University, underscoring WUST's commitment to fostering meaningful global partnerships in high-impact research domains.

A Global Forum for AI-Powered Cancer Innovation

Held in hybrid mode, ICAIO 2025 served as a vibrant interdisciplinary platform for the exchange of research, ideas, and innovations at the forefront of oncology. The conference enabled participation both on-campus in Pune and virtually, reflecting its commitment to global accessibility and inclusive academic engagement.

Participants from multiple continents explored how artificial intelligence is transforming every dimension of cancer care, from early detection and diagnosis to treatment planning, personalized medicine, and drug discovery. Five focused research tracks structured the program:

• AI in Basic Principles of Oncology, exploring how AI enhances understanding of cancer biology, tumorigenesis, and pathophysiology

• AI in Public Health, examining AI's role in population-based cancer screening, prevention, and reducing healthcare disparities in resource-limited settings

• AI in Solid Malignancies, focusing on AI applications in breast, lung, colorectal, prostate, and other solid tumors across diagnostics, treatment decision-making, and predictive modeling

• AI in Hematological Malignancies, addressing AI-driven approaches to leukemia, lymphoma, and myeloma diagnosis, genomic profiling, and clinical trial optimization

• AI in Special Topics in Oncology, spotlighting emerging AI applications in rare cancers, immunotherapy, palliative care, and multidisciplinary cancer treatment

WUST's Role: Advisory Leadership and Global Representation

WUST's involvement in ICAIO 2025 extended beyond co-organization. Soureen Dutta Roy of Washington University of Science and Technology served on the conference's prestigious Advisory Committee, joining an internationally distinguished panel that included scholars from Kennesaw State University, the University of Florida, SUNY Binghamton, and the Indian Institute of Technology. WUST's representation at this advisory level reflects the university's standing as a recognized academic partner in global research initiatives.

This participation aligns directly with WUST's research mission: to bridge the gap between knowledge and practice by facilitating cutting-edge research, collaboration, and innovation, and to nurture global leaders in academia and industry through impactful scholarship.

WUST's Growing Strength in AI and Healthcare Research

WUST's co-organization of ICAIO 2025 is not an isolated event, it reflects a deep and expanding research culture at the university in precisely the domains the conference addresses. WUST faculty and collaborators have published actively in AI-driven healthcare, including work on deep learning for ovarian cancer classification, machine learning models for breast cancer diagnosis, AI frameworks for gallbladder cancer detection, and hybrid transfer learning for brain tumor diagnosis.

This body of research positions WUST as a natural and credible partner for a conference dedicated to the application of artificial intelligence in oncology. The university's Triple Mission, Degree, Skill, and Career, extends into its research agenda: preparing graduates not just for the evolving job market, but for meaningful contributions to global science and medicine.

Distinguished Keynote Speakers

ICAIO 2025 was honored by the presence of several distinguished keynote speakers:

• Dr. Sachi Nandan Mohanty, Professor, VIT-AP University, Amaravati, India, General Chair of the conference

• Dr. Jayant Sastri Goda, Professor and Clinician Scientist in Radiation Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India

• Dr. Abhay Somani, Senior Interventional Cardiologist, Ruby Hall Clinic, Pune, bringing a clinical perspective on AI integration in medicine

• Dr. Dharanidhar Dang, Assistant Professor, University of Texas, San Antonio, USA

Their addresses spanned critical frontiers, from machine learning models for radiation therapy optimization, to AI-enabled clinical trials, to the ethical considerations of deploying AI within healthcare systems, collectively underscoring the transformative and urgent role of AI in modern oncology.

A Rigorous International Technical Program

ICAIO 2025 featured a competitive peer review process. Submitted research papers underwent single-blind review by an international Technical Program Committee comprising experts from institutions across Nigeria, Serbia, Germany, the UAE, Saudi Arabia, New Zealand, Spain, India, and the United States. The program was organized under the leadership of Dr. Tanupriya Choudhury (University of Petroleum and Energy Studies, Dehradun) and Reshma Nitin Pise of Vishwakarma University as Program Chairs, with Sanjesh Pawale as Program Co-Chair.

The technical sessions spanned all five conference tracks, offering attendees a comprehensive view of the current state and future direction of AI in oncology, from foundational cancer biology to real-world clinical deployment.

Publication and Academic Impact

All accepted full-length papers presented at ICAIO 2025 will be published in Springer Nature Conference Proceedings (Scopus Indexed), ensuring broad international visibility and academic impact. The Springer Nature association reflects the conference's commitment to high-quality, peer-reviewed scientific dissemination and positions ICAIO as a credible, enduring venue for research at the nexus of AI and cancer care.

Strengthening WUST's Global Research Mission

By co-organizing ICAIO 2025, WUST reaffirmed its dedication to advancing interdisciplinary research with real-world impact. The conference provided a dynamic environment for exchanging ideas, inspiring innovation, and building the kind of meaningful international partnerships that WUST champions through its research programs and global campus network.

Artificial intelligence holds extraordinary promise for oncology, accelerating diagnosis, personalizing treatment, predicting outcomes, and ultimately improving survival rates for millions of cancer patients worldwide. WUST is proud to have played a founding role in a conference dedicated to turning that promise into clinical reality, and looks forward to deepening its engagement with the global oncology research community in the years ahead.

For more information about ICAIO 2025, visit icaio.vupune.ac.in | To learn more about research at WUST, visit research.wust.edu